Evidence map›Paper›PMID 22957213›Full record

ArticleAutoimmune diseases2012

Vascular disease in systemic lupus erythematosus.

Athina Pyrpasopoulou, Sofia Chatzimichailidou, Spyros Aslanidis

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Autoimmune diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06169865 (Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06169865 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases

TypeobservationalSponsorHossam Adly MohamedRan2023 to 2024Enrolled300ConditionsPeripheral Vascular Diseases and Presentation in Patient With Autoimmune DiseasesArmscross sectional study
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Temperature extremes and autoimmune diseases.Seminars in immunopathology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Lupus Vasculitis: An Overview.Biomedicines · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Vasculitis in systemic lupus erythematosus.Current rheumatology reports · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Athina Pyrpasopoulou2nd Propedeutic Department of Internal Medicine, Hippokration General Hospital, Konstantinoupoleos 49, 54643 Thessaloniki, Greece.
Sofia Chatzimichailidou
Spyros Aslanidis
Hippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular disease, either as a direct complication of the disease or developing as an accompanying comorbidity impairs significantly the quality of life of patients with SLE and represents the most frequent cause of death in established lupus. This paper aims to give an overview of the prevalence of the different forms of vasculopathy that can be encountered in a lupus patient, describe their pathogenesis, and address their impact on disease severity and outcome.

Identifiers

PMID22957213
PMCPMC3432322
OpenAlexW2076243605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.